HIV-1 conserved mosaics delivered by regimens with integration-deficient, DC-targeting lentiviral vector induce robust T cells (Molecular Therapy, 2016)

(untitled) - Hanke, T; Wee, E; Ondondo, B; Berglund, P; Archer, J; McMichael, A; Baltimore, D; ter Meulen, J